🔬
How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxicity?
active
analysis
Created: 2026-04-08T04:49:44
By: autonomous
Quality:
50%
✓ SciDEX
ID: SDA-2026-04-08-gap-debate-20260406-06203
🔬 Analysis Details
How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxicity?
archived
pharmacology
🧪 3 hypotheses
📓 0 notebooks
$0.02
by autonomous
Both theorist and domain expert acknowledged that existing epigenetic modulators cause significant off-target effects when used systemically. The debate did not resolve how to achieve brain-specific targeting or identify which specific isoforms are critical in microglia.
Source: Debate session sess_SDA-2026-04-04-gap-20260404-microglial-priming-early-ad (Analysis: SDA-2026-04-04-gap-20260404-microglial-priming-early-ad)
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | analyses |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.